About Ids van der Weij
Form D filings for Diceros Therapeutics in 2024 list Ids van der Weij as director.
Ids van der Weij first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Ids van der Weij in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ids van der Weij works with at each company, as listed on that company's latest Form D.
Diceros Therapeutics, Inc. · Form D/A, Aug 5, 2024
